NCT00893841View on ClinicalTrials.gov

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Bipolar Depression
Interventions
DRUG

quetiapine (Seroquel) XR

tablets and caplets, take with liquid before bedtime

DRUG

quetiapine (Seroquel) XR

tablets, take with liquid before bedtime

DRUG

placebo

placebo

DRUG

pramipexole dihydrochloride

tablets and caplets, take with liquid before bedtime

Trial Locations (9)

92108

Affiliated Research Institute, San Diego

98033

Eastside Therapeutic Resource, Kirkland

T6L 6W6

Dr. P. Chokka, Edmonton

V2A 4M4

Penticton Regional, Penticton

V6Z 2L4

Copeman Neuroscience Centre, Vancouver

B1S 2E8

AK Munshi Medical Inc., Sydney

N6A 4H1

Regional Mental Health Care - London, London

H1N 3M5

Hôpital Louis-H.Lafontaine, Montreal

G1R 2W8

Clinique Marie Fitzbach, Québec

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.

OTHER